Log in to save to my catalogue

Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer

Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_537504b77a584db7a48979724411a17a

Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer

About this item

Full title

Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer

Publisher

London: Nature Publishing Group UK

Journal title

NPJ precision oncology, 2023-03, Vol.7 (1), p.24-24, Article 24

Language

English

Formats

Publication information

Publisher

London: Nature Publishing Group UK

More information

Scope and Contents

Contents

We performed a prospective study of circulating immune cell changes after stereotactic body radiotherapy (SBRT) in 50 early-stage NSCLC patients. We found no significant increase in CD8
+
cytotoxic T lymphocytes at first follow-up (the primary endpoint) but detected a significant increase in expanding Ki-67
+
CD8
+
and Ki-67
+<...

Alternative Titles

Full title

Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_537504b77a584db7a48979724411a17a

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_537504b77a584db7a48979724411a17a

Other Identifiers

ISSN

2397-768X

E-ISSN

2397-768X

DOI

10.1038/s41698-023-00358-z

How to access this item